Successful Medical Treatment Using Tolvaptan of Ventricular Septal Rupture Following Myocardial Infarction

Although improved treatments for acute myocardial infarction (AMI) have considerably reduced the mortality of AMI in the past two decades, the treatment for ventricular septal rupture (VSR)-a rare but life-threatening mechanical complication of AMI-still remains quite challenging. We herein describe...

Descripción completa

Detalles Bibliográficos
Autores principales: Terada, Kazushi, Takagi, Kensuke, Morishima, Itsuro, Tsuboi, Hideyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643170/
https://www.ncbi.nlm.nih.gov/pubmed/28824059
http://dx.doi.org/10.2169/internalmedicine.8402-16
Descripción
Sumario:Although improved treatments for acute myocardial infarction (AMI) have considerably reduced the mortality of AMI in the past two decades, the treatment for ventricular septal rupture (VSR)-a rare but life-threatening mechanical complication of AMI-still remains quite challenging. We herein describe the case of a high-surgical-risk patient with VSR after AMI who was successfully treated using tolvaptan (a novel V(2)-receptor antagonist) without any mechanical support.

Ejemplares similares